Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00951171 · ClinicalTrials.gov registry record · Phase 3
Effect of Cervical Occlusion During Intrauterine Insemination (IUI)
A Phase 3 study, sponsored by Women and Infants Hospital of Rhode Island.
- Terminated
- Registry status
- Phase 3
- Development phase
- 93
- Enrollment target
NCT00951171: Clinical Trial Phase 3 study, sponsored by Women and Infants Hospital of Rhode Island.
NCT00951171 is a Phase 3 study that was terminated before completion, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 93 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00951171, a Phase 3 study, was terminated before completion, sponsored by Women and Infants Hospital of Rhode Island.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 93 participants
- Enrollment target
Study Summary
Study Hypothesis: There is a difference in pregnancy rates between intrauterine insemination (IUI) in cycles performed with cervical occlusion by a balloon catheter designed for sonohysterograms as compared to those performed with a standard inseminator. The investigators will compare pregnancy rates in patients undergoing routine IUI either with balloon occlusion or with standard insemination. The patients will receive the standard clinical care per the investigators' office guidelines, except they will be randomized to insemination with either of two catheters.
Primary Outcome
positive beta HCG test
Interventions
- PROCEDURE Intrauterine Insemination
- PROCEDURE IUI with the standard inseminator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Why NCT00951171 stopped before completion
NCT00951171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Intrauterine Insemination is the first listed.
NCT00951171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00951171 about?
NCT00951171 is a clinical study titled "Effect of Cervical Occlusion During Intrauterine Insemination (IUI)". Study Hypothesis: There is a difference in pregnancy rates between intrauterine insemination (IUI) in cycles performed with cervical occlusion by a balloon catheter designed for sonohysterograms as compared to those performed with a standard inseminator. The investigators will compare pregnancy rat...
What is the current status of trial NCT00951171?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 93 participants. The study started on 2009-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00951171?
The interventions under investigation include: Intrauterine Insemination (PROCEDURE), IUI with the standard inseminator (PROCEDURE).
Who is sponsoring clinical trial NCT00951171?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00951171's enrollment target sits among peer trials
93 1722nd of 2000 higher than 278 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia